产品简要
公司名称 :
HUABIO
产品类型 :
抗体
产品名称 :
增殖细胞核抗原小鼠单克隆抗体[A6-G11](EM111201)
目录 :
EM111201
规格 :
单克隆
价格 :
A6-G11
克隆性 :
单克隆
宿主 :
小鼠
共轭标签 :
未共轭
克隆名称 :
A6-G11
反应物种 :
人类, 小鼠, 大鼠
应用 :
免疫印迹, 流式细胞仪, 免疫组化-石蜡切片
更多信息或购买 :
产品信息
Catalog# :
EM111201
产品名称 :
增殖细胞核抗原小鼠单克隆抗体[A6-G11](EM111201)
类别 :
Mouse monoclonal primary
共轭 :
未共轭
克隆性 :
单克隆
克隆编号 :
A6-G11
宿主 :
小鼠
应用 :
免疫印迹, 免疫组化-P, FC
应用w/稀释 :
WB: 1:1, 000-1:2, 000;免疫组化-P:1:200;FC:1:100
反应物种 :
人类, 小鼠, 大鼠
免疫原 :
Recombinant protein within human PCNA aa 1-261.
抗体亚型 :
IgG1
靶蛋白 :
增殖细胞核抗原
靶标.UniProt数据库 :
P12004
靶标.同义词 :
ATLD2 antibody; cb16 antibody; Cyclin antibody; DNA polymerase delta auxiliary protein antibody; etID36690.10 antibody; fa28e03 antibody; fb36g03 antibody; HGCN8729 antibody; MGC8367 antibody; Mutagen-sensitive 209 protein antibody; OTTHUMP00000030189 antibody; OTTHUMP00000030190 antibody; PCNA antibody; Pcna/cyclin antibody; PCNA_HUMAN antibody; PCNAR antibody; Polymerase delta accessory protein antibody; Proliferating cell nuclear antigen antibody; wu:fa28e03 antibody; wu:fb36g05 antibody
Target function/background :
PCNA (Proliferating cell nuclear antigen) is an auxiliary protein of DNA polymerase delta and is involved in the control of eukaryotic DNA replication by increasing the polymerase's processibility during elongation of the leading strand. It induces a robust stimulatory effect on the 3'-5' exonuclease and 3'-phosphodiesterase, but not apurinic-apyrimidinic (AP) endonuclease, APEX2 activities.
产品形式 :
液体
纯化 :
蛋白质A亲和纯化
浓度 :
2微克/微升
储存缓冲液 :
1*PBS (pH7.4), 0.2% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
储存空调 :
Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.
分子量 :
29 kDa
供应商 :
HUABIO
Volume :
100ul
价格 :
325
launch date :
2020&prior
更多信息或购买 :
公司信息
HUABIO
Boston, Massachusetts
support@huabio.com
https://www.huabio.com
1-857-353-6600
公司总部: 美国
Founded in 2007, HUABIO is dedicated to developing high-quality antibodies that advance innovation. We are passionate about the accuracy, efficiency, and consistency of our products. That is why we have invested in new production platforms, like recombinant rabbit monoclonals, alpaca nanobodies, and adopted aggressive QA standards to deliver cutting-edge antibodies with uncompromised quality.
We hope to see you at your next discovery!